ARTERIAL GIPERTENZIYADA FARMAKOLOGIK DAVOLASH STRATEGIYALARI.

Authors

  • Hamdamova Surayyo Zayniddinovna O`qituvchi:
  • Usmonov Shoxjaxon Bazirgon o‘g‘li O`qituvchi: Qorako`l Abu Ali ibn Sino nomidagi jamoat salomatligi texnikumi

Abstract

Arterial gipertenziya (AG) yurak-qon tomir kasalliklari orasida eng keng tarqalgan va o‘lim ko‘rsatkichlari yuqori bo‘lgan patologiyalardan biridir. Ushbu maqolada arterial gipertenziyani davolashda qo‘llaniladigan asosiy farmakologik guruhlar, ularning ta’sir mexanizmlari, klinik samaradorligi, kombinatsiyalangan terapiya tamoyillari hamda dori tanlashda individual yondashuv masalalari yoritilgan. Shuningdek, dori xavfsizligi, polifarmatsiya va bemorlarning davolashga rioya qilishi bilan bog‘liq muammolar tahlil qilingan.

References

1. World Health Organization. Hypertension. WHO, 2023.

2. Williams B. et al. ESC/ESH Guidelines for the management of arterial hypertension. European Heart Journal, 2018.

3. Whelton P.K. et al. 2017 ACC/AHA Hypertension Guideline. Hypertension, 2018.

4. Messerli F.H. Antihypertensive therapy. The Lancet, 2019.

5. Carey R.M. Resistant hypertension. New England Journal of Medicine, 2020.

6. Burnier M. Drug adherence in hypertension. European Heart Journal, 2019.

7. Kaplan N.M. Clinical hypertension. Wolters Kluwer, 2021.

8. Poulter N.R. Combination therapy in hypertension. Journal of Hypertension, 2020.

9. Weber M.A. Pharmacologic treatment of hypertension. Circulation, 2019.

10. Bakris G.L. Hypertension and kidney disease. Kidney International, 2020.

Downloads

Published

2026-01-24

How to Cite

Hamdamova Surayyo Zayniddinovna, & Usmonov Shoxjaxon Bazirgon o‘g‘li. (2026). ARTERIAL GIPERTENZIYADA FARMAKOLOGIK DAVOLASH STRATEGIYALARI. New Modern Researchers: Modern Proposals and Solutions, 3(1), 128–132. Retrieved from https://incop.org/index.php/new/article/view/3133